Lisuride toxicity in a pediatric patient

Lisuride Maleate (Dopergin) is semi synthetic ergot alkaloid used for a variety of medical conditions. It is licensed for use in Canada, EU and Middle East countries and is marketed by various drug companies. There are no reported cases of lisuride toxicity in the literature on Google Search or Pub...

Descripción completa

Detalles Bibliográficos
Autores principales: Alahmadi, Tahani A., Mujawar, Quais M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Case Snippet
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665066/
https://www.ncbi.nlm.nih.gov/pubmed/23723628
http://dx.doi.org/10.4103/0974-2700.110803
_version_ 1782271200991379456
author Alahmadi, Tahani A.
Mujawar, Quais M.
author_facet Alahmadi, Tahani A.
Mujawar, Quais M.
author_sort Alahmadi, Tahani A.
collection PubMed
description Lisuride Maleate (Dopergin) is semi synthetic ergot alkaloid used for a variety of medical conditions. It is licensed for use in Canada, EU and Middle East countries and is marketed by various drug companies. There are no reported cases of lisuride toxicity in the literature on Google Search or Pub med Search. Herein, we present a case of accidental overdose of lisuride maleate in a 21-month-old Saudi male and further clinical course and management. The aim of this report was to document the unusual features of lisuride toxicity in pediatric patients and to guide physicians for its management.
format Online
Article
Text
id pubmed-3665066
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36650662013-05-30 Lisuride toxicity in a pediatric patient Alahmadi, Tahani A. Mujawar, Quais M. J Emerg Trauma Shock Case Snippet Lisuride Maleate (Dopergin) is semi synthetic ergot alkaloid used for a variety of medical conditions. It is licensed for use in Canada, EU and Middle East countries and is marketed by various drug companies. There are no reported cases of lisuride toxicity in the literature on Google Search or Pub med Search. Herein, we present a case of accidental overdose of lisuride maleate in a 21-month-old Saudi male and further clinical course and management. The aim of this report was to document the unusual features of lisuride toxicity in pediatric patients and to guide physicians for its management. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3665066/ /pubmed/23723628 http://dx.doi.org/10.4103/0974-2700.110803 Text en Copyright: © Journal of Emergencies, Trauma, and Shock http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Snippet
Alahmadi, Tahani A.
Mujawar, Quais M.
Lisuride toxicity in a pediatric patient
title Lisuride toxicity in a pediatric patient
title_full Lisuride toxicity in a pediatric patient
title_fullStr Lisuride toxicity in a pediatric patient
title_full_unstemmed Lisuride toxicity in a pediatric patient
title_short Lisuride toxicity in a pediatric patient
title_sort lisuride toxicity in a pediatric patient
topic Case Snippet
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665066/
https://www.ncbi.nlm.nih.gov/pubmed/23723628
http://dx.doi.org/10.4103/0974-2700.110803
work_keys_str_mv AT alahmaditahania lisuridetoxicityinapediatricpatient
AT mujawarquaism lisuridetoxicityinapediatricpatient

Ejemplares similares